Osteal Therapeutics

Dallas, TX · Founded 2013 · Privately Held (backing)

Developer of infection therapeutics designed to reduce the mortality, morbidity, and cost of care associated with musculoskeletal infections. Osteal Therapeutics is based in Dallas, TX and was founded in 2013. It was valued at $576 million at its later-stage round in Nov 2025, the last priced event on record. It has raised $133 million across 4 recorded rounds; the latest was a $15.6 million early-stage round in Oct 2025.

PMV mark · valuation
$575.6M
Oct 2026
Priced at
its later-stage round
Nov 2025
Total raised
$133.1M
Last round
Early Stage VC
Oct 2025

Who backs Osteal Therapeutics?

9 investors
InvestorType
Johnson & Johnson JJDCVenture capital
Asteroid Partners—
GOS Capital—
Gideon Strategic Partners—
HM Capital—
HM Venture Partners—
Medvest Capital—
Prism Ventures—
Zimmer Biomet—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Osteal Therapeutics investors

9 investors are on record for Osteal Therapeutics, including Johnson & Johnson JJDC, Asteroid Partners, GOS Capital and Gideon Strategic Partners. The early-stage round in Oct 2025 drew 10 investors.

Free account
More of Osteal Therapeutics with a free account
  • ·Watch Osteal Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Osteal Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View